Heron Therapeutics

HRTX · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings about 1 month ago

Total Revenue

$40.6M

Previous year: $40.8M

Previous year: $3.18M

+17.9%

G&A expense

$13.5M

Previous year: $12.1M

+10.8%

Sales & marketing expense

$12.2M

Previous year: $11.1M

Previous year: $25.8M

Loading...

Heron Therapeutics

Unlock previous datapoints

Upgrade

Heron Therapeutics

Unlock previous datapoints

Upgrade

Heron Therapeutics Revenue by Segment

Heron Therapeutics Revenue by Geographic Location

Revenue by Segment

ZYNRELEF Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

APONVIE Revenue

CapyFin.com

CINVANTI Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

SUSTOL Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Revenue by Geographic Location

United States Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$148M

P/E Ratio

N/A

Sector

N/A

Industry

N/A

52-Week High

$2.4

52-Week Low

$0.759

R&D expense

$3.75M

G&A expense

$13.5M

Sales & marketing expense

$12.2M

Other expense, net

-$2.99M

Basic shares outstanding

188.03M

Products

Get in Touch

Resources

Heron Therapeutics

Heron Therapeutics

Heron Therapeutics

Heron Therapeutics Revenue by Segment

Heron Therapeutics Revenue by Geographic Location

Revenue by Segment

ZYNRELEF Revenue

APONVIE Revenue

CINVANTI Revenue

SUSTOL Revenue

Revenue by Geographic Location

United States Revenue

Revenue & Expenses

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics